NCT05090150

Brief Summary

The investigators propose A Sequential Multiple Assignment Randomized Trial of scalable interventions for ART delivery in South Africa- the SMART ART study-a randomized study to test adaptive ART delivery for persons with detectable viral load and/or not engaged in care.The types of differentiated service delivery (DSD) that will be examined in this study are incentives, community-based ART, and home delivery. The study plans to enroll up to 900 participants-people living with HIV and who are eligible for ART and living in KwaZulu-Natal, South Africa. The study aims to maximize the proportion of ART eligible persons living with HIV who achieve viral suppression at 18 months. The study will also evaluate the preferences of clients and providers for differentiated service delivery, and evaluate the cost effectiveness of adaptive HIV treatment for those who are not engaged in care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
874

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 22, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

November 2, 2021

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 3, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 3, 2025

Completed
Last Updated

January 12, 2026

Status Verified

January 1, 2026

Enrollment Period

3.7 years

First QC Date

September 16, 2021

Last Update Submit

January 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Viral suppression at 18 months

    The primary outcome is viral suppression at 18 months among the combined group of persons living with HIV who have detectable viral load and persons not engaged in care at enrollment.

    18 months

Secondary Outcomes (4)

  • Retention in Care

    12 months

  • Time to ART initiation

    6 months

  • Engagement in care

    18 months

  • Comparison to viral suppression and retention outcomes from similar local clinics

    18 months

Study Arms (6)

Best clinic practices

NO INTERVENTION

Participants start with best clinic practices and continue for 18 months (including participants who are non-responders at month 6 and are randomized to stay in their original arm)

Best clinic practices plus lottery incentives

EXPERIMENTAL

Participants start with best clinic practices plus lottery incentives and continue for 18 months (including participants who are non-responders at month 6 and are randomized to stay in the original arm)

Other: Best clinic practices + conditional lottery incentives

Randomized from best clinic practices to smart lockers

EXPERIMENTAL

Second randomization into community ART through the use of smart lockers

Other: Smart Lockers (Pele boxes)Other: Best clinic practices

Randomized from best clinic practices to home delivery

EXPERIMENTAL

Second randomization into home ART delivery

Other: Home delivery of ARTOther: Best clinic practices

Randomized from best clinic practices plus lottery incentives to smart lockers

EXPERIMENTAL

Second randomization into community ART through the use of smart lockers

Other: Smart Lockers (Pele boxes)Other: Best clinic practices + conditional lottery incentives

Randomized from best clinic practices plus lottery incentives to home delivery

EXPERIMENTAL

Second randomization into home ART delivery

Other: Home delivery of ARTOther: Best clinic practices + conditional lottery incentives

Interventions

Home ART refill and monitoring, adherence support

Randomized from best clinic practices plus lottery incentives to home deliveryRandomized from best clinic practices to home delivery

Decentralized ART refills and monitoring, adherence support

Randomized from best clinic practices plus lottery incentives to smart lockersRandomized from best clinic practices to smart lockers

Conditional lottery incentives Welcome back service (friendly providers, SMS, adherence support) Fast-track ART

Best clinic practices plus lottery incentivesRandomized from best clinic practices plus lottery incentives to home deliveryRandomized from best clinic practices plus lottery incentives to smart lockers

Continue with best clinic practices

Randomized from best clinic practices to home deliveryRandomized from best clinic practices to smart lockers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be 18 years or older
  • Able and willing to provide informed consent for study procedures
  • Must self report that they will reside in the study community for the duration of follow-up
  • Living with HIV and eligible for ART by national guidelines, have a detectable viral load greater than the lower limit of detection and/or not engaged in care, and are stable clinically (CD4\>100 cells, no moderate/severe screening laboratory abnormalities for kidney function i.e. eGFR \>50 mL/min/1.73m2, not receiving treatment for active tuberculosis or other opportunistic infections).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Sciences Research Council Sweetwaters

Sweetwaters, KwaZulu-Natal, South Africa

Location

Related Publications (1)

  • van Heerden A, Szpiro A, Ntinga X, Celum C, van Rooyen H, Essack Z, Barnabas R. A Sequential Multiple Assignment Randomized Trial of scalable interventions for ART delivery in South Africa: the SMART ART study. Trials. 2023 Jan 17;24(1):32. doi: 10.1186/s13063-022-07025-x.

Study Officials

  • Ruanne V Barnabas, DPhil

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SEQUENTIAL
Model Details: Participants are first randomly assigned to two interventions:either best clinic practices or best clinic practices with a conditional lottery incentive. This stage lasts 6 months. Participants who do not meet the criteria for non-response will continue in the assigned intervention arm. Non-responders will be rerandomized to continue in the clinic intervention arm (standard of care), community ART (smart lockers), or home delivery.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 16, 2021

First Posted

October 22, 2021

Study Start

November 2, 2021

Primary Completion

July 3, 2025

Study Completion

July 3, 2025

Last Updated

January 12, 2026

Record last verified: 2026-01

Locations